Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

DBCOND0115216Disorders of Glucose Metabolism Infections

Methicillin Resistant Staphylococcus Aureus Infection (MRSA) is the indication for 3 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: Methicillin-Resistant Staphylococcus Aureus Infection · MRSA - Methicillin Resistant Staphylococcus Aureus Infection · Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Classified under: Disorders of Glucose Metabolism
Infections
Myopathy
Nervous System Diseases
Pancreatic Diseases
Signs and Symptoms
Indicated drugs: Dalfopristin
Omadacycline
Quinupristin

Resolves to

Vocabularies

ICD-10A49.0SNOMED CT154316009MedDRA10041925UMLSC0038160

What you can answer from here — as of November 01, 2026

3Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

10Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Methicillin Resistant Staphylococcus Aureus Infection (MRSA) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account